logo
N -Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura
Transfusion medicine education: an integral foundation of effective blood management
How we incorporate molecular typing of donors and patients into our hospital transfusion service
Incidental arterial phlebotomy of a whole blood donor
Treatment of refractory thrombotic thrombocytopenic purpura with N -acetylcysteine: a case report
Development of a validated exam to assess physician transfusion medicine knowledge
Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest
Peripheral blood progenitor cell collection by two programs for autologous and allogeneic transplantation
Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients
High-dose methotrexate in the mobilization of hematopoietic stem cells for patients with non-Hodgkin's lymphoma: a twelve-year study in a single center
Total nucleated cells as a sole predictor of distinct targets of hematopoietic potential (CD34+ cells) in cord blood units: the results of a large series analysis in autologous cord blood units
Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor
Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
Storage time affects umbilical cord blood viability
Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia
Defining a reference range for cold agglutinin titers
The p.R168Q mutation is associated with the Bw phenotype and a predicted decrease in the stability of the resulting ABO glycosyltransferase
Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis
Hemolytic disease of the fetus and newborn caused by anti-Lan
Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction
An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides
T-cell suppression by red blood cells is dependent on intact cells and is a consequence of blood bank processing
Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion
Improved blood utilization using real-time clinical decision support
Neonatal blood transfusion as transmission route in chronic hepatitis C
Peripheral blood stem cell collection in low-weight children: retrospective comparison of two apheresis devices
Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest
Continuing Medical Education Program in Transfusion
Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Novel alleles of Lan− in Japanese populations
Integration of the transfusion medicine and coagulation services
Integration of the transfusion medicine and coagulation services
Who advocates for cryoprecipitate?
Who advocates for cryoprecipitate?
Routine neonatal coagulation testing increases use of fresh-frozen plasma